Stein R, Fisch M, Beetz R, Matani Y, Doi Y, Hohenfellner K, Bürger R A, Abol-Enein H, Hohenfellner R
Department of Urology, University of Mainz, School of Medicine, Germany.
Br J Urol. 1997 Mar;79(3):354-61. doi: 10.1046/j.1464-410x.1997.00008.x.
To determine the late complications and consequences for renal function, vitamin and acid-base metabolism after application of the Mainz Pouch I (MZP-I) technique in children and young adults.
To November 1994, the MZP-I procedure was carried out in 463 patients at our institution, 91 of whom were children and adolescents (< or = 20 years old) using bladder augmentation in 21 and a continent cutaneous stoma in 70. A minimum follow-up of 1 year was possible in 87 patients or 163 renal units (RUs) with a mean of 5.5 years (range 1-10.5).
At the last examination, 23 of 55 (42%) preoperatively dilated RUs had improved. 131 of the 163 RUs (80%) were stable and nine RUs (5.5%) showed a slight clinical asymptomatic increase in the upper tract dilatation. Through an extraperitoneal flank incision, 11% of the RUs which developed stenosis at the ureterocolic anastomosis were successfully reimplanted (16% in patients with neurogenic disorders, 17% with pre-operative irradiation and 5% in the remaining patients). Two of 32 patients with an intussuscepted and invaginated ileal nipple required re-operation due to incontinence, but none of the patients with an appendiceal stoma were incontinent. Open revision of a stomal stenosis was performed in three and endoscopic treatment in nine patients. In 54 patients, the levels of vitamins A, B1, B2, B6, E, folic and bile acid were within normal ranges. There was no significant decrease in vitamin B12 levels after operation. In none of the patients with normal pre-operative creatinine values had the levels increased and none developed severe acidosis or bowel neoplasm.
The MZP-I is recommended as a technique for bladder augmentation or continent urinary diversion in children and young adults, with an acceptable complication rate which offers long-term protection of the upper urinary tract.
确定在儿童和青年中应用美因茨I型贮尿囊(MZP-I)技术后肾功能、维生素及酸碱代谢方面的远期并发症及后果。
至1994年11月,我院对463例患者实施了MZP-I手术,其中91例为儿童和青少年(≤20岁),21例采用膀胱扩大术,70例采用可控性皮肤造口术。87例患者或163个肾单位(RUs)至少随访了1年,平均随访5.5年(范围1 - 10.5年)。
在最后一次检查时,55个术前扩张的肾单位中有23个(42%)情况有所改善。163个肾单位中有131个(80%)情况稳定,9个肾单位(5.5%)上尿路扩张有轻微临床无症状性增加。通过腹膜外腰部切口,输尿管结肠吻合口发生狭窄的肾单位中有11%成功进行了再植术(神经源性疾病患者中为16%,术前接受放疗的患者中为17%,其余患者中为5%)。32例回肠乳头套叠和内陷的患者中有2例因尿失禁需要再次手术,但阑尾造口的患者均无尿失禁情况。3例患者进行了造口狭窄的开放性修复,9例患者接受了内镜治疗。54例患者的维生素A、B1、B2、B6、E、叶酸和胆汁酸水平在正常范围内。术后维生素B12水平无显著下降。术前肌酐值正常的患者中,肌酐水平均未升高,也无患者发生严重酸中毒或肠道肿瘤。
MZP-I技术推荐用于儿童和青年的膀胱扩大术或可控性尿流改道,其并发症发生率可接受,能对上尿路提供长期保护。